An interview published in Acta Sanitaria, in which he explains that his company is present in the market with biosimilars for the treatment of female fertility and the treatment of osteoporosis.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
